Insulin Degludec in Clinical Practice: A Review of Japanese Real-World Data

被引:0
|
作者
Kohei Kaku
Michael Lyng Wolden
Jacob Hyllested-Winge
Emil Nørtoft
机构
[1] Kawasaki Medical School,
[2] Novo Nordisk A/S,undefined
[3] Novo Nordisk Pharma Ltd,undefined
来源
Diabetes Therapy | 2017年 / 8卷
关键词
Degludec; Dose; Hypoglycemia; Insulin; Japan; Quality of life; Real-world;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:189 / 195
页数:6
相关论文
共 50 条
  • [1] Insulin Degludec in Clinical Practice: A Review of Japanese Real-World Data
    Kaku, Kohei
    Wolden, Michael Lyng
    Hyllested-Winge, Jacob
    Nortoft, Emil
    [J]. DIABETES THERAPY, 2017, 8 (01) : 189 - 195
  • [2] INSULIN DEGLUDEC IN CLINICAL PRACTICE: A SYSTEMATIC REVIEW OF JAPANESE REAL-WORLD DATA
    Kaku, K.
    Wolden, M. L.
    Hyllested-Winge, J.
    Nortoft, E.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A681 - A681
  • [3] The effect of insulin degludec in people with type 2 diabetes in real-world clinical practice in China
    Zhu, D.
    Chang, X.
    Lehrskov, L. L.
    Li, L.
    Nordentoft, M.
    Quan, J.
    Sha, Y.
    Xing, Z.
    Yang, C.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
  • [4] COST-EFFECTIVENESS OF SWITCHING TO INSULIN DEGLUDEC (IDEG) IN REAL-WORLD CLINICAL PRACTICE IN ITALY
    Haldrup, S.
    Lapolla, A.
    Gundgaard, J.
    Wolden, M. L.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A478 - A479
  • [5] Real-World or Controlled Clinical Trial Data in Real-World Practice
    Wu, Ting-Hui
    Yang, James Chih-Hsin
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : 470 - 472
  • [6] Impact of Insulin Degludec in Type 2 Diabetes: Real-World Data on Effectiveness and Safety
    Paola Ponzani
    Cesare Berra
    Alessandra Di Lelio
    Paola Del Sindaco
    Chiara Di Loreto
    Francesco Reggiani
    Giuseppe Lucisano
    Maria Chiara Rossi
    [J]. Diabetes Therapy, 2018, 9 : 2209 - 2218
  • [7] Impact of Insulin Degludec in Type 2 Diabetes: Real-World Data on Effectiveness and Safety
    Ponzani, Paola
    Berra, Cesare
    Di Lelio, Alessandra
    Del Sindaco, Paola
    Di Loreto, Chiara
    Reggiani, Francesco
    Lucisano, Giuseppe
    Rossi, Maria Chiara
    [J]. DIABETES THERAPY, 2018, 9 (06) : 2209 - 2218
  • [8] Long-Term Safety and Clinical Outcomes with Insulin Degludec/Insulin Aspart Treatment in Japanese Patients with Diabetes: A Real-World, Prospective, Observational Study
    Katabami, Takuyuki
    Eriksen, Kirsten T.
    Yamamoto, Yuiko
    Ishigaki, Yasushi
    [J]. ADVANCES IN THERAPY, 2022, 39 (01) : 544 - 561
  • [9] Long-Term Safety and Clinical Outcomes with Insulin Degludec/Insulin Aspart Treatment in Japanese Patients with Diabetes: A Real-World, Prospective, Observational Study
    Takuyuki Katabami
    Kirsten T. Eriksen
    Yuiko Yamamoto
    Yasushi Ishigaki
    [J]. Advances in Therapy, 2022, 39 : 544 - 561
  • [10] Exploratory outcomes of the use of insulin degludec in the real world: data from the Association of British Clinical Diabetologists nationwide degludec audit
    Colosimo, Santo
    Ruan, Yue
    Lumb, Alistair
    Rea, Rustam
    Mcdonald, Paula
    Bain, Stephen C.
    Abraham, Ralph
    Gallen, Ian
    Ryder, Robert E. J.
    [J]. BRITISH JOURNAL OF DIABETES, 2024, 24 (01): : 45 - +